We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trikeâ„¢ Phase i/ii Clinical Trial PR Newswire TAMPA, Florida, Sept. 12, 2019 TAMPA, Florida, Sept. 12, 2019...
GT Biopharma GTB-1550 Multi-Targeted Bispecific Drug Conjugate Strategically positioned in new class of ADC Drugs PR Newswire TAMPA, Florida, June 13, 2019 TAMPA, Florida, June 13, 2019...
GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in Chicago PR Newswire TAMPA, Florida, May 29, 2019 TAMPA, Florida, May 29, 2019...
GT Biopharma Announces Completion of Management Restructuring PR Newswire TAMPA, Florida, March 26, 2019 TAMPA, Florida, March 26, 2019 /PRNewswire/ --Â GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA...
GT Biopharma's Chairman and Chief Executive Officer Raymond W Urbanski, M.D., Ph.D Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Collaboration PR Newswire LOS ANGELES...
GT Biopharma's Chairman and Chief Executive Officer Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Collaboration PR Newswire LOS ANGELES, August 29, 2018 LOS ANGELES...
GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of Finance PR Newswire LOS ANGELES, August 24, 2018 LOS ANGELES, August 24, 2018 /PRNewswire/ -- Biopharma...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions